Institute of Life Science 2 Internal Atrium
Professor Deyarina Gonzalez

Professor Deyarina Gonzalez

Professor, Biomedical Sciences

Telephone number

+44 (0) 1792 295384

Email address

Research Links

Available For Postgraduate Supervision


Deya is a Professor of Molecular Medicine, and a founding member of the Reproductive Biology and Gynaecological Oncology Group at Swansea University Medical School.
She considers herself a translational scientist in the areas of female infertility and cancer, with the ultimate goal of developing functional platforms and bringing targeted therapies into the clinic for the benefit of patients. Her projects involve close collaborations with the NHS and the private sector in the areas of multicellular 3D-patient derived models of disease and precision medicines including Antibody Drug Conjugates and Exosomes. She is a co-PI of the CEAT-Cluster for Epigenomics and ADC therapeutics project (£2.6M), where she leads the ADC programme.
Deya is also the Chair of Research Ethics & Governance at Swansea University Medical School. She serves as editorial member of several journals in the areas of reproductive medicine and oncology. Deya is the Regional non-clinical Champion for South West Wales within the Wales Cancer Research Centre.

Areas Of Expertise

  • • Gynaecological cancers
  • • 3D patient-derived models
  • • functional tissue and blood biomarkers
  • • advanced targeted therapies
  • • female infertility
  • • tumour microenvironment
  • • drug discovery
  • • inflammation

Career Highlights

Teaching Interests

Deya lectures on the Genetics, Biochemistry and Applied Medical Sciences BSc Degree programmes and on the MSc in Nanomedicine programme. She is a Fellow of The Higher Education Academy and she regularly hosts MSCi students.  


Deya’s research focuses on biomarker discovery and translational medicine in the areas of female infertility and gynaecological cancers. She has applied her expertise in inflammation, angiogenesis, vascular permeability, reproductive biology and cancer to develop multicellular 3D patient derived models for use as tools in biomarker discovery and drug development. Her clinical interests are Polycystic Ovary Syndrome (PCOS), endometriosis, and gynaecological cancers (endometrial and ovarian cancer).
Her drug discovery projects include identification of functional biomarkers of disease and their translation as diagnostic tools and therapeutic opportunities for cancer patients. Deya is interested in developing novel HTS characterisation platforms for development of immunotherapies including antibody drug conjugates and exosomes. Research projects in the areas of female infertility, include the identification of biomarkers for pre-disposition of infertile women to develop gynaecological cancers and the relationship between stress and different women’s reproductive health conditions.